Definitive Contract 75N91023C00027
Award Date 8/25/23
Potential Completion Date 8/24/25
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Spanish Fork, UT 84660, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original...
- <p>This is a $1,999,386.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Avoneaux Medical Institute, LLC, a veteran-owned limited liability company. The contract is for the development of spatial micropurification technology under SBIR Topic 403. The contract is a definitive, firm fixed-price contract with a period of performance ending on September 18, 2024.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...
- This is a $2,000,000 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mimetas US Inc., a self-certified small disadvantaged business based in Montgomery Village, Maryland. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens. This system aims to enable personalized medicine approaches...
- This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Myriad RBM, Inc. for the development of a clinical automated multiplex affinity capture technology to detect low abundance cancer-related proteins and peptides. The contract has a firm fixed price of $1,126,627.00 and was awarded on September 28, 2007, with a scheduled completion date of June 27, 2010. As an SBIR Phase I contract, this award represents the initial research and...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract is for the development of glycosylation-specific research under SBIR Topic 294, with a ceiling value of $148,569. SBIR contracts are set-aside for small businesses to engage in research and development for the government. This Phase I contract represents the initial research and feasibility...
- This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Cell Microsystems Inc., a small business manufacturer of tools for imaging, sorting, and isolating single cells and colonies. The $2,295,432.00 contract, which is part of the Small Business Innovation Research (SBIR) program, supports the integration of Cell Microsystems' SCOPE SEQ technology with air flow capabilities for the molecular analysis of glioblastoma, an aggressive...
- <p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI) to Biofluidica, Inc., a for-profit organization located in Baton Rouge, Louisiana. The contract has a ceiling value of $199,517.00 and is a Firm Fixed Price Definitive Contract. The contract was awarded on September 30, 2010 with an ultimate completion date of August 29, 2011. As an SBIR Phase I contract, this award supports early-stage research and development efforts.